New Issue: Science’s Impossible Questions. Read Now

Study of Cellular Protein Disposal Garners Chemistry Nobel

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Proteins are the building blocks of living things, and much scientific research has been dedicated to figuring out how cells produce their myriad proteins. Fewer researchers were interested in studying the opposite problem: how cells identify and break down unwanted proteins. Now a trio of scientists who did just that has been rewarded with the Nobel Prize in Chemistry for their seminal work in solving this mystery.

Aaron Ciechanover (center) and Avram Hershko (left) of the Israel Institute of Technology, together with Irwin Rose of the University of California at Irvine (right), received the honor ¿for the discovery of ubiquitin-mediated protein degradation,¿ according to the selection committee. Ubiquitin, itself a polypeptide protein, identifies protein molecules that are ready to be destroyed. Once singled out and tagged by ubiquitin, the labeled proteins are sent to the cell's proteasome, which chops them into small pieces. ¿The collaborative work of this international group of researchers has given us an important close-up view of the regulatory processes taking place inside human cells and what happens when these processes don't work properly,¿ notes Charles P. Casey of the University of Wisconsin-Madison and current president of the American Chemical Society,

Protein degradation guided by ubiquitin, which derives its name from the Latin word meaning everywhere, occurs throughout the body. The Nobel committee noted that the laureates' work in the 1980s paved the way to understanding other cell processes such as DNA repair and gene transcription. In addition, some diseases, including cystic fibrosis and cervical cancer, involve improper protein breakdown, so a better understanding of how the process should work could shed light on new treatment options.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe